Predictors of Length of Hospital Stay After Complete Repair for Tetralogy of Fallot: A Prospective Cohort Study

Journal of the American Heart Association
Laura Mercer-RosaElizabeth Goldmuntz

Abstract

We sought to identify patient and surgical factors associated with time to hospital discharge in patients undergoing complete repair for tetralogy of Fallot. We performed a prospective cohort study of patients with tetralogy of Fallot admitted for complete repair between May 1, 2012 and June 2, 2017 at Children's Hospital of Philadelphia with detailed demographic, clinical, and operative characteristics. The primary outcome was time to hospital discharge. Cox proportional hazards models were used to identify patient and operative predictors of time to hospital discharge. We enrolled 151 subjects, 62.8% male, 65.6% non-Hispanic white, and 9.9% non-Hispanic black. The median time to hospital discharge was 7 days (interquartile range 4, 12). Five patients died in the hospital, all of whom underwent tetralogy of Fallot repair beyond the neonatal period. Greater birth weight was associated with higher rate of hospital discharge (hazard ratio [HR]=1.35, 95% confidence interval (CI) =1.11, 1.64), while absent pulmonary valve versus pulmonary stenosis (HR=0.27, 95% CI=0.08, 0.91), pulmonary valve atresia versus pulmonary stenosis (HR=0.57, 95% CI=0.33, 0.97), presence of aortopulmonary collaterals (HR=0.44, 95% CI=0.24, 0.84), complete...Continue Reading

References

Nov 24, 1999·Circulation·F A PigulaR A Jonas
Aug 7, 2003·The Annals of Thoracic Surgery·William T MahleKirk R Kanter
Aug 14, 2003·The Journal of Pediatrics·Jane W NewburgerGil Wernovsky
Sep 23, 2003·The Journal of Thoracic and Cardiovascular Surgery·Elisabeth I van DongenDesmond Bohn
Dec 11, 2003·The Journal of Thoracic and Cardiovascular Surgery·Adriano CarottiRoberto M Di Donato
May 1, 2007·The Journal of Thoracic and Cardiovascular Surgery·J William GaynorThomas L Spray
Jan 28, 2010·The Annals of Thoracic Surgery·Karl F WelkeBrian S Diggs
Feb 23, 2010·The Annals of Thoracic Surgery·Kirk R KanterPamela R Carlock
Jan 12, 2012·Circulation. Cardiovascular Quality and Outcomes·Shuenn-Nan ChiuMei-Hwan Wu
Aug 7, 2012·Pediatric Cardiology·Rachel McDonaldPunkaj Gupta
Jan 15, 2013·The Journal of Thoracic and Cardiovascular Surgery·Laura Mercer-RosaElizabeth Goldmuntz
Apr 23, 2013·The Journal of Thoracic and Cardiovascular Surgery·Roxanne E KirschGeoffrey L Bird
Jan 1, 2012·World Journal for Pediatric & Congenital Heart Surgery·Jeffrey Phillip JacobsJohn E Mayer
Jul 25, 2013·The Journal of Thoracic and Cardiovascular Surgery·Matthew B SteinerParthak Prodhan
Oct 26, 2013·European Heart Journal·Elisa LlurbaLluís Cabero
Jun 3, 2014·Asian Cardiovascular & Thoracic Annals·Alexander C EgbeShubhika Srivastava
Sep 10, 2014·The Annals of Thoracic Surgery·Sara K PasqualiJeffrey P Jacobs
Dec 3, 2014·The Annals of Thoracic Surgery·Syed Murfad PeerPranava Sinha
Dec 15, 2016·Circulation. Cardiovascular Interventions·Juan Pablo SandovalKyong-Jin Lee
Mar 16, 2017·Circulation. Cardiovascular Imaging·Deane YimLars Grosse-Wortmann
May 4, 2017·The Journal of Thoracic and Cardiovascular Surgery·Daud LodinTara Karamlou
Jul 2, 2017·The Journal of Thoracic and Cardiovascular Surgery·Travis J WilderEdward J Hickey

❮ Previous
Next ❯

Citations

May 10, 2021·International Journal of Cardiology·Lee H SterlingAriane J Marelli
May 18, 2021·Journal of the American Heart Association·Xie WuFuxia Yan
Aug 10, 2021·Frontiers in Cardiovascular Medicine·Jennifer A FaerberLaura Mercer-Rosa
Sep 21, 2021·Interactive Cardiovascular and Thoracic Surgery·Yibing FangShuhua Luo

❮ Previous
Next ❯

Software Mentioned

Stata

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.